FDA inspection
Samsung Biologics Co., Ltd.: FDA inspection ending Feb 28, 2023
FDA inspection 1201856 · Voluntary Action Indicated (VAI) · Yeonsu District
Key facts
| Inspection ID | 1201856 |
|---|---|
| Firm | Samsung Biologics Co., Ltd. |
| FEI number | 3010479596 |
| Address | 300 Songdobaiodae-Ro |
| City | Yeonsu District |
| Country | Korea (the Republic of) |
| Fiscal year | 2023 |
| Inspection end date | Feb 28, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data